IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction

Not Applicable

Terminated

• Conditions: Acute Myocardial Infarction

• Registration Number: NCT01532206
• Lead Sponsor: Johns Hopkins University

Brief Summary

Remote ischemic preconditioning has proven beneficial in patients undergoing percutaneous coronary intervention and coronary artery bypass surgery. Animal studies suggest remote ischemic preconditioning increases levels of interleukin 10. The investigators aim to determine whether remote ischemic preconditioning results in an increase in IL-10 levels in patients following acute myocardial infarction.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-02-09
• Study First Submitted QC: 2012-02-13
• Study First Posted: 2012-02-14
• Status Verified: 2013-03
• Study Start: 2013-03
• Primary Completion: 2014-02
• Study Completion: 2014-05
• Last Update Submitted: 2016-03-24
• Last Update Posted: 2016-03-25

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

• Acute myocardial infarction

Exclusion Criteria

• Cardiogenic shock Active ischemia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Interleukin 10 levels	24 hours following RIPC

Trial Locations

Locations (1)

Johns Hopkins Hospital; 🇺🇸 Baltimore, Maryland, United States